Trial Profile
Dose-Ranging, Safety And Efficacy Of Cathflo Activase (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Catheter thrombosis
- Focus Therapeutic Use
- 27 Sep 2011 Planned end date changed from 1 Dec 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 20 May 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 20 May 2009 Planned end date changed from Dec 2008 to Dec 2010 as reported by ClinicalTrials.gov.